[Retracted] Correlation between the Variability of Glycosylated Hemoglobin and Cardiovascular Risk in New-Onset T2DM Patients

Table 1

Comparison of clinical data between the CVD group and non-CVD group.

Clinical data	CVD group (n = 24)	Non-CVD group (n = 88)	t/χ^2	value
Gender			0.027	0.869
Male	13	46
Female	11	42
Average age (years)	67.13 ± 11.28	58.35 ± 10.94	3.462	0.001
BMI (kg/m^2)	22.90 ± 3.17	22.85 ± 3.52	0.063	0.949
Drinking history n (%)	8	28	0.019	0.888
Smoking history n (%)	6	21	0.013	0.908
Hypertension n (%)	11	39	0.018	0.895
Hyperlipidemia n (%)	5	14	0.069	0.793
Drug treatment n (%)			6.793	0.009
Diabetes	11	65
Insulin	13	23
Laboratory index
FPG (mmol/L)	9.40 ± 1.58	7.22 ± 1.46	6.371	0
TC (mmol/L)	5.27 ± 1.28	5.24 ± 1.19	0.108	0.914
TG (mmol/L)	2.11 ± 0.53	2.09 ± 0.48	0.177	0.859
LDL-C (mmol/L)	3.23 ± 0.97	3.16 ± 0.85	0.347	0.729
HDL-C (mmol/L)	1.26 ± 0.23	1.28 ± 0.30	0.303	0.763
SUA (μmol/L)	371.45 ± 108.64	367.24 ± 112.56	0.164	0.87
HbA1c (%)	9.12 ± 1.29	8.11 ± 1.34	3.298	0.001
HGI level n (%)			30.065	0
Low HGI	1	36
Medium HGI	4	34
High HGI	19	18